Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial-Reference-Cited by-同舟云学术

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

Published:2020-06 Issue:10240 Volume:395 Page:1845-1854
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zhu Feng-Cai,Li Yu-Hua,Guan Xu-Hua,Hou Li-Hua,Wang Wen-Juan,Li Jing-Xin,Wu Shi-Po,Wang Bu-Sen,Wang Zhao,Wang Lei,Jia Si-Yue,Jiang Hu-Dachuan,Wang Ling,Jiang Tao,Hu Yi,Gou Jin-Bo,Xu Sha-Bei,Xu Jun-Jie,Wang Xue-Wen,Wang Wei,Chen Wei

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia;Li;N Engl J Med,2020

3. Compassionate use of remdesivir for patients with severe Covid-19;Grein;N Engl J Med,2020

4. Clinical course and mortality risk of severe COVID-19;Weiss;Lancet,2020

5. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study;Cowling;Lancet Public Health,2020

Cited by 1129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular vesicles-based “all-in-one” vaccine platform triggers mucosal immunity against respiratory viruses;Nano Today;2024-12

2. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

3. Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8+ T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette–Guerin;Vaccines;2024-09-06

4. The delivery device of SARS-CoV-2 mucosal vaccine matters;Nature Immunology;2024-09-03

5. Recent research advances in the development of Dabie Banda virus vaccines;PLOS Neglected Tropical Diseases;2024-08-29